Latest News


 

SyndactylyUCI Alpha Stem Cell Clinic - Clinical Research Coordinator Training Program (CRCTP)

UCI

June 22, 2022


SyndactylyCIRM Board Approves Funding for Clinical Trials Targeting Epilepsy and Dysphagia | California's Stem Cell Agency

CIRM

May 26, 2022

Leigh TurnerUltragenyx announces first patient dosed in phase 1/2 clinical study of UX053

Ultragenyx

December 1, 2021

Leigh TurnerBusinesses selling non-FDA-approved stem cell products grew four-fold in five years, UCI study says

UCI News

November 4, 2021

Michael Nguyen and Dr. Leonid GroysmanNatural killer cells show potential to treat COVID-19 symptoms

UCI Health

August 13, 2021

Diomics Corp LogoFDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

CIRM Blog

June 15, 2021

Diomics Corp LogoCIRM Funded Trial for Parkinson’s Treats First Patient

CIRM Blog

September 14, 2020

Diomics Corp LogoDiomics Corporation and University of California, Irvine Collaborate to Enable Cell Therapy Clinical Trial for Type 1 Diabetes

GlobalNewsWire

September 4, 2020

SyndactylyCIRM Award for COVID-19 Treatment

ASCC

August 5, 2020

SyndactylyWorking with the City of Hope in clinical study for potential treatment for COVID-19

ASCC

July 24, 2020

SyndactylyA phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19

CIRM Press Release

July 23, 2020

SyndactylyPotential Risks of Treatment with Unapproved Regenerative Medicine Products

FDA

July 22, 2020

SyndactylyIdentifying the Risks of Unproven Regenerative Medicine Therapies

JAMA Network

June 17, 2020

SyndactylyCIRM Board Expands COVID-19 Efforts

CIRM Blog

April 10, 2020

SyndactylyClinical trials: separating the wheat from the chaff

CIRM Blog

June 14, 2019